Grote F K, Oostdijk W, de Muinck Keizer-Schrama S M P F, Dekker F W, Verkerk P H, Wit J M
Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
J Pediatr Endocrinol Metab. 2005 Nov;18(11):1031-8. doi: 10.1515/jpem.2005.18.11.1031.
BACKGROUND/AIMS: Growth monitoring is almost universally performed, but few data are available on which referral criteria and diagnostic work-up are used worldwide for children with short stature.
A short questionnaire, containing questions on auxological screening and on diagnostic criteria for short stature, was sent to all members of the European Society of Paediatric Endocrinology (ESPE) and to several pediatric endocrinologists outside Europe.
Responses were received from 36 countries. In 27 (75%) a child health care program existed and in 14 (39%) there was a protocol for referral of children with growth retardation. Height for age was mostly used as a referral criterion. Sixteen countries (45%) reported having a guideline in secondary health care for diagnostic work-up. Although all countries agreed on having biochemical, radiological and/or genetic tests in the diagnostic work-up, there was a wide variety of recommended tests.
There is little consensus on referral criteria and diagnostic work-up of children with short stature among industrialized countries. There is a need to establish evidence-based guidelines.
背景/目的:生长监测几乎在全球范围内普遍开展,但关于全球范围内用于身材矮小儿童的转诊标准和诊断检查的数据却很少。
向欧洲儿科内分泌学会(ESPE)的所有成员以及欧洲以外的几位儿科内分泌学家发送了一份简短问卷,其中包含有关体格检查和身材矮小诊断标准的问题。
收到了来自36个国家的回复。27个国家(75%)存在儿童保健项目,14个国家(39%)有生长发育迟缓儿童的转诊方案。年龄别身高大多被用作转诊标准。16个国家(45%)报告在二级医疗保健中有诊断检查的指南。尽管所有国家都同意在诊断检查中进行生化、放射学和/或遗传学检查,但推荐的检查种类繁多。
工业化国家在身材矮小儿童的转诊标准和诊断检查方面几乎没有共识。有必要制定基于证据的指南。